212 related articles for article (PubMed ID: 24788555)
1. Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657).
Cureton EL; Yau C; Alvarado MD; Krontiras H; Ollila DW; Ewing CA; Monnier S; Esserman LJ
Ann Surg Oncol; 2014 Sep; 21(9):2889-96. PubMed ID: 24788555
[TBL] [Abstract][Full Text] [Related]
2. Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
Shin HC; Han W; Moon HG; Im SA; Moon WK; Park IA; Park SJ; Noh DY
Ann Surg Oncol; 2013 Aug; 20(8):2582-9. PubMed ID: 23504119
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
[TBL] [Abstract][Full Text] [Related]
4. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
Mamtani A; Sevilimedu V; Le T; Morrow M; Barrio AV
Cancer; 2022 Feb; 128(3):471-478. PubMed ID: 34597420
[TBL] [Abstract][Full Text] [Related]
5. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
6. Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16).
Cho WK; Park W; Choi DH; Kim YB; Kim JH; Kim SS; Kim K; Kim JH; Ahn SJ; Lee SY; Lee J; Kim SW; Kwon J; Ahn KJ
Clin Breast Cancer; 2019 Feb; 19(1):78-86. PubMed ID: 30241965
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
8. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Therapy Combined With Oncoplastic Reduction for High-Stage Breast Cancer Patients.
Broecker JS; Hart AM; Styblo TM; Losken A
Ann Plast Surg; 2017 Jun; 78(6S Suppl 5):S258-S262. PubMed ID: 28452833
[TBL] [Abstract][Full Text] [Related]
10. Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy.
Min SY; Lee SJ; Shin KH; Park IH; Jung SY; Lee KS; Ro J; Lee S; Kim SW; Kim TH; Kang HS; Cho KH
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e697-705. PubMed ID: 21129858
[TBL] [Abstract][Full Text] [Related]
11. Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival.
Sutton TL; Schlitt A; Gardiner SK; Johnson N; Garreau JR
J Surg Oncol; 2020 Dec; 122(8):1761-1769. PubMed ID: 33125715
[TBL] [Abstract][Full Text] [Related]
12. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
[TBL] [Abstract][Full Text] [Related]
13. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?
Schnitt SJ
Am J Clin Pathol; 2003 Oct; 120(4):485-8. PubMed ID: 14560560
[No Abstract] [Full Text] [Related]
15. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
[TBL] [Abstract][Full Text] [Related]
16. Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).
Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
Breast Cancer Res Treat; 2018 Sep; 171(2):335-344. PubMed ID: 29808288
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
[No Abstract] [Full Text] [Related]
18. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
[TBL] [Abstract][Full Text] [Related]
19. Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Campbell JI; Yau C; Krass P; Moore D; Carey LA; Au A; Chhieng D; Giri D; Livasy C; Mies C; Rabban J; Sarode VR; Singh B; Esserman L; Chen YY
Breast Cancer Res Treat; 2017 Aug; 165(1):181-191. PubMed ID: 28577078
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.
Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]